Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 5, 2011, Pages 743-752

  Asimaki, Angeliki ^a   Tandri, Harikrishna ^d   Duffy, Elizabeth R ^c   Winterfield, Jeffrey R ^a   MacKey Bojack, Shannon ^e   Picken, Maria M ^f   Cooper, Leslie T ^g   Wilber, David J ^f   Marcus, Frank I ^h   Basso, Cristina ⁱ   Thiene, Gaetano ⁱ   Tsatsopoulou, Adalena ^j   Protonotarios, Nikos ^j   Stevenson, William G ^a   McKenna, William J ^k   Gautam, Shiva ^b   Remick, Daniel G ^c   Calkins, Hugh ^d   Saffitz, Jeffrey E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Department of Medicine ^*  (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e Jesse E Edwards Registry of Cardiovascular Diseases   (United States)

^f LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j Yiannis Protonotarios Medical Center   (Greece)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

ARVC; Cytokines; Desmosomes; Gamma catenin; Giant cells; Myocarditis; Sarcoidosis

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLAKOGLOBIN; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CARDIOMYOPATHY; CELL JUNCTION; CYTOKINE PRODUCTION; DESMOSOME; GRANULOMATOUS INFLAMMATION; HEART ARRHYTHMIA; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; SARCOIDOSIS; ADOLESCENT; ADULT; AGED; ANIMAL; ANIMAL MODEL; AUTOPSY; BIOPSY; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CHILD; DRUG EFFECT; FEMALE; HEART RIGHT VENTRICLE FUNCTION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

ADOLESCENT; ADULT; AGED; ANIMALS; ARRHYTHMIAS, CARDIAC; AUTOPSY; BIOPSY; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL4; CHILD; DESMOSOMES; FEMALE; GAMMA CATENIN; HUMANS; INTERCELLULAR JUNCTIONS; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; MODELS, ANIMAL; MYOCARDITIS; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; SARCOIDOSIS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, RIGHT; YOUNG ADULT;

EID: 84555208273     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.111.964890     Document Type: Article

References (45)

1. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373:1289-1300.
2. Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, McKenna WJ, Calkins H, Saffitz JE. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2009;360:1075-1084.
3. Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol. 2009;20:578-583.
4. Vasaiwala SC, Finn C, Delpriore J, Leya F, Gagermeier J, Akar JG, Santucci P, Dajani K, Bova D, Picken MM, Basso C, Marcus F, Wilber DJ. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol. 2009;20:473-476.
5. Ladyjanskaia GA, Basso C, Hobbelink MG, Kirkels JH, Lahpor JR, Cramer MJ, Thiene G, Hauer RN, V Oosterhout MF. Sarcoid myocarditis with ventricular tachycardia mimicking ARVD/C. J Cardiovasc Electrophysiol. 2010;21:94-98.
6. Granér M, Lommi J, Kupari M, Räisänen-Sokolowski A, Toivonen L. Multiple forms of sustained monomorphic ventricular tachycardia as common presentation in giant-cell myocarditis. Heart. 2007;93:119-121. (Pubitemid 46094073)
7. Blauwet LA, Cooper LT. Antimicrobial agents for myocarditis: target the pathway, not the pathogen. Heart. 2010;96:494-495.
8. Nash CL, Panaccione R, Sutherland LR, Meddings JB. Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept-a tumour necrosis factor-alpha antagonist. Can J Gastroenterol. 2001;15:607-611. (Pubitemid 33062057)
9. Liu W, Feng W, Wang F, Li W, Gao C, Zhou B, Ma M. Osteoprotegerin/ RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease. Exp Mol Pathol. 2008;84:213-217.
10. Ahuja SS, Estrada CA, Lindsey ML. Crosstalk between cytotoxic T-lymphocyte associated antigen-4 and interleukin-12 in cytotoxic T-lymphocyte-mediated myocarditis: adding another link to the chain. Circ Res. 2007;101:218-220. (Pubitemid 47344067)
11. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, Njoku DB, Rose NR. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol. 2004;165:1883-1894. (Pubitemid 39578368)
12. Saffitz JE, Green KG, Kraft WJ, Schechtman KB, Yamada KA. Effects of diminished expression of connexin43 on gap junction number and size in ventricular myocardium. Am J Physiol Heart Circ Physiol. 2000;278: H1662-H1670. (Pubitemid 30395580)
13. Godin-Ethier J, Pelletier S, Hanafi LA, Gannon PO, Forget MA, Routy JP, Boulassel MR, Krzemien U, Tanguay S, Lattouf JB, Arbour N, Lapointe R. Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. J Immunol. 2009;183:7752-7760.
14. MacKenzie CR, González RG, Kniep E, Roch S, Däubener W. Cytokine mediated regulation of interferon-gamma-induced IDO activation. Adv Exp Med Biol. 1999;467:533-539. (Pubitemid 32202199)
15. Singer CF, Kronsteiner N, Hudelist G, Marton E, Walter I, Kubista M, Czerwenka K, Schreiber M, Seifert M, Kubista E. Interleukin-1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype. Clin Cancer Res. 2003;9:4877-4883. (Pubitemid 37323293)
16. Pimentel RC, Yamada KA, Kleber AG, Saffitz JE. Autocrine regulation of myocyte Cx43 expression by VEGF. Circ Res. 2002;90:671-677. (Pubitemid 34640885)
17. Yamada K, Green KG, Samarel AM, Saffitz JE. Distinct pathways regulate expression of cardiac electrical and mechanical junction proteins in response to stretch. Circ Res. 2005;97:346-353. (Pubitemid 41216139)
18. Asimaki A, Syrris P, Wichter T, Matthias P, Saffitz JE, McKenna WJ. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2007;81:964-973. (Pubitemid 47580249)
19. Marcus FI, McKenna WJ. Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado DA, Cox MG, Daubert J, Fontaine G, Gear K, Hauer RN, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri HM, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D); proposed modification of the task force criteria. Circulation. 2010;121:1533-1541.
20. Knight PR, Sreekumar A, Siddiqui J, Laxman B, Copeland S, Chinnaiyan A, Remick DG. Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis. Shock. 2004;21:26-30.
21. Rosenstein ED, Zucker MJ, Kramer N. Giant cell myocarditis: most fatal of autoimmune diseases. Semin Arthritis Rheum. 2000;30:1-16. (Pubitemid 30644068)
22. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Olsen EG, Schoen FJ. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3-14.
23. Eiken HG, Oie E, Damas JK, Yndestad A, Bjerkeli V, Aass H, Simonsen S, Geiran OR, Tonnessen T, Christensen G, Froland SS, Gullestad L, Attramada H, Aukrust P. Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein130 in end-stage human heart failure. Eur J Clin Invest. 2001;31:389-397. (Pubitemid 32476958)
24. Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H. Alterations in Janus kinase (JAK)-signal transducers and activations of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation. 2003;107:789-802.
25. Gwechenberger M, Hülsmann M, Berger R, Graf S, Springer C, Stanek B, Pacher R. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure. J Heart Lung Transplant. 2004;23:839-844. (Pubitemid 38960760)
26. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy or myocarditis? Circulation. 1996;94:983-991. (Pubitemid 26292851)
27. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen WH, Shou Z, Liu P. Tissue expression and immunolocalization of tumor necrosis factor-alpha in post-infarction dysfunctional myocardium. Circulation. 1999;99:1492-1498. (Pubitemid 29140917)
28. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543-1553. (Pubitemid 38856961)
29. Agrawal RA, Koyani CN, Singh R. Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res. 2010;61:269-280.
30. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001;103:2055-2059. (Pubitemid 32373007)
31. Bradham WS, Boskurt B, Gunasinghe H, Mann D, Spinale FG. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a clinical perspective. Cardiovasc Res. 2002;53:822-830. (Pubitemid 34261020)
32. Dibbs Z, Thornby J, White BG, Mann DL. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol. 1999;33:1935-1942.
33. Amagai M. Autoimmune and infectious skin diseases that target desmogleins. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:524-537.
34. Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M. Epithelial tight junctions in intestinal inflammation. Ann NY Acad Sci. 2009;1165:294-300.
35. Schmidt A, Koch PJ. Desmosomes: just cell adhesion or is there more? Cell Adh Migr. 2007;1:28-32.
36. Kaplan SR, Gard JJ, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A, Squarcioni CP, McKenna WJ, Thiene G, Basso C, Brousse N, Fontaine G, Saffitz JE. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm. 2004;1:3-11. (Pubitemid 38647241)
37. Fidler LM, Wilson GJ, Liu F, Cui X, Scherer SW, Taylor GP, Hamilton RM. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations. J Cell Mol Med. 2009;13:4219-4228.
38. Saffitz JE, Hames KY, Kanno S. Remodeling of gap junctions in ischemic and nonischemic forms of heart disease. J Membr Biol. 2007;218:65-71. (Pubitemid 350132117)
39. Severs NJ, Dupont E, Thomas N, Kaba R, Rothery S, Jain R, Sharpey K, Fry CH. Alterations in cardiac connexin expression in cardiomyopathies. Adv Cardiol. 2006;42:228-242. (Pubitemid 43805867)
40. Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, Darbar D. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm. 2010;7:438-444.
41. Torre-Amione G, Kapadia S, Lee J, Durant JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
42. Symons JA, Young PR, Duff GW. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci U S A. 1995;92: 1714-1718.
43. Campian ME, Verberne HJ, Hardziyenka M, de Groot EAA, van Moerkerken AF, van Eck-Smit BLF, Tan HL. Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Eur J Nucl Med Mol Imaging. 2010;37:2079-2085.
44. Fuse K, Kodama M, Okura Y, Ito M, Aoki Y, Hirono S, Kato K, Hanawa H, Aizawa Y. Levels of serum interleukin-10 reflect disease activity in patients with cardiac sarcoidosis. Jpn Circ J. 2000;64:755-759.
45. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72:561-566.